|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/68 | (2006.01) |
| G01N 33/587 | (2013.01) | ||
| G01N 33/58 | (2006.01) | ||
| G01N 33/6845 | (2013.01) |
| (11) | Patento numeris | 3761035 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20191942.0 |
| Europos patento paraiškos padavimo data | 2017-08-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-01-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201662376788 P | 2016-08-18 | US |
| (72) |
MARLOW, Michael , US
SENNETT, Michael , US
SCHNEIDER, Michael , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | ASSAY FOR DETERMINING POTENTIAL TO SELF-ASSOCIATION OF A PROTEIN USING CONCENTRATION-DEPENDENT SELF-INTERACTION NANOPARTICLE SPECTROSCOPY |
| ASSAY FOR DETERMINING POTENTIAL TO SELF-ASSOCIATION OF A PROTEIN USING CONCENTRATION-DEPENDENT SELF-INTERACTION NANOPARTICLE SPECTROSCOPY |